Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice

Baron, 1998, Postprandial hyperglycaemia and α-glucosidase inhibitors, Diabetes Research and Clinical Practice, 40, S51, 10.1016/S0168-8227(98)00043-6 Truscheit, 1981, Chemistry and biochemistry of microbial α-glucosidase inhibitors, Angewandte Chemie, 20, 744, 10.1002/anie.198107441 Horii, 1986, Synthesis and α-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents, Journal of Medicinal Chemistry, 29, 1038, 10.1021/jm00156a023 Hillebrand, 1988, Efficacy and tolerability of the glucosidase inhibitor acarbose (Bay-g5421) evaluated by clinical data pool, Therapie, 43, 153 Madar, 1989, The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats, The Journal of Nutrition, 119, 2023, 10.1093/jn/119.12.2023 Miura, 1998, Effects of acarbose (α-glucosidase inhibitor) on disaccharase activity in small intestine in KK-Ay and ddY mice, Journal of Nutritional Science and Vitaminology, 44, 371, 10.3177/jnsv.44.371 Tuomilehto, 1994, Acarbose and nutrient intake in non-insulin dependent diabetes mellitus, Diabetes Research and Clinical Practice, 26, 215, 10.1016/0168-8227(94)90063-9 Coniff, 1995, Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus, The American Journal of Medicine, 98, 443, 10.1016/S0002-9343(99)80343-X Coniff, 1995, A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes, Diabetes Care, 18, 928, 10.2337/diacare.18.7.928 Wolever, 1995, One-year acarbose treatment raises fasting serum acetate in diabetic patients, Diabetic Medicine, 12, 164, 10.1111/j.1464-5491.1995.tb00448.x Carrascosa, 1997, Acarbose-induced acute severe hepatotoxicity, Lancet, 349, 698, 10.1016/S0140-6736(05)60134-1 Kihara, 1997, Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose, Journal of Gastroenterology, 32, 777, 10.1007/BF02936954 Diaz-Gutierrez, 1998, Acarbose-induced acute hepatitis, American Journal of Gastroenterology, 93, 481, 10.1111/j.1572-0241.1998.481_1.x Charpentier, 2000, Management of drugs affecting blood glucose in diabetic patients with renal failure, Diabetes and Metabolism, 26, 73 Flourie, 1986, Colonic metabolism of wheat starch in healthy humans: effect on fecal outputs and clinical symptoms, Gastroenterology, 90, 111, 10.1016/0016-5085(86)90082-X Carlson, 1983, A bean α-amylase inhibitor formulation (starch blocker) is ineffective in man, Science, 219, 393, 10.1126/science.6184780 Layer, 1985, Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans, Gastroenterology, 88, 1895, 10.1016/0016-5085(85)90016-2 Boivin, 1988, Gastrointestinal and metabolic effects of amylase inhibition in diabetes, Gastroenterology, 94, 387, 10.1016/0016-5085(88)90426-X Jain, 1989, Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying, Gastroenterology, 96, 377, 10.1016/0016-5085(89)91561-8 Koike, 1995, Effect of a wheat amylase inhibitor on canine carbohydrate digestion, gastrointestinal function, and pancreatic growth, Gastroenterology, 108, 1221, 10.1016/0016-5085(95)90223-6 Choudhury, 1996, Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormones, Gastroenterology, 111, 1313, 10.1053/gast.1996.v111.pm8898646 Takada, 1998, Chemo-enzymatic synthesis of galactosylmaltooligosaccharidonolactone as a substrate analogue inhibitor for mammalian α-amylase, Journal of Biochemistry, 123, 508, 10.1093/oxfordjournals.jbchem.a021965 Reeves, 1993, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, The Journal of Nutrition, 123, 1939, 10.1093/jn/123.11.1939 Hassid, 1957, Anthrone-H2SO4 method, Methods in Enzymology, 3, 34, 10.1016/S0076-6879(57)03345-5 Ranganath, 1998, Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect, Diabetic Medicine, 15, 120, 10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I Juntti-Berggren, 2000, Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes, Diabetes Nutrition and Metabolism, 13, 7